Hydrochloride methanol → 3-(5-(2,5-Difluorophenyl)-3-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propan-1-amine
반응식
[N:1]([CH2:4][CH2:5][CH2:6][C:7]1([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[N:11]([C:12]2[S:13][C:14]3[CH2:15][N:16]([CH3:21])[CH2:17][CH2:18][C:19]=3[N:20]=2)[N:10]=[C:9]([C:22]2[CH:27]=[C:26]([F:28])[CH:25]=[CH:24][C:23]=2[F:29])[S:8]1)=[N+]=[N-].Cl.CO>CO.[Pd]>[F:29][C:23]1[CH:24]=[CH:25][C:26]([F:28])=[CH:27][C:22]=1[C:9]1[S:8][C:7]([CH2:6][CH2:5][CH2:4][NH2:1])([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[N:11]([C:12]2[S:13][C:14]3[CH2:15][N:16]([CH3:21])[CH2:17][CH2:18][C:19]=3[N:20]=2)[N:10]=1참가 물질
반응물 2
생성물 1
시약·촉매·용매 2
실험 절차
To a solution of 2-(2-(3-azidopropyl)-5-(2,5-difluorophenyl)-2-phenyl-1,3,4-thiadiazol-3(2H)-yl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine (0.046 g, 0.090 mmol) in 2 mL of methanol was added 1N HCl/MeOH (0.27 mL, 0.27 mmol) followed by 10% Pd/C (10 mg). The mixture was hydrogenated under a balloon atmosphere for 1 hour then filtered through GF paper, and the filtrate concentrated in vacuo. The residue was triturated with diethyl ether, filtered, washed with ether and dried in vacuo to afford the desired product as a bright yellow solid, 0.027 g, 50%. MS ESI (+) m/z 486 (M+1) detected; 1H NMR (400 MHz, CDCl3) δ 7.59 (m, 1H), 7.45 (d, 2H, J=7.6 Hz), 7.32 (m, 2H), 7.26 (m, 1H), 7.06 (m, 2H), 3.50 (m, 2H), 3.43 (m, 1H), 2.77 (t, 2H, J=6.9 Hz), 2.68 (m, 2H), 2.56 (m, 2H), 2.46 (s, 3H), 2.41 (m, 1H), 1.99 (m, 1H), 1.55 (m, 1H) ppm.
후처리
- filtrationthen filtered through GF paper
- concentrationthe filtrate concentrated in vacuo
- customThe residue was triturated with diethyl ether
- filtrationfiltered
- washwashed with ether
- customdried in vacuo
출처 및 근거
- ORD 기록
- ord-71267b850dce43948ce796564a7677ff
- 출처 데이터셋
- uspto-grants-2010_09
- 특허 번호
- US07795282B2
반응 노트
불러오는 중…